XML 85 R95.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities $ (36,762) $ (44,119)
Capital expenditures (7,439) (8,895)
Proceeds from asset dispositions 3,204 7,774
Cash transferred in sale of subsidiaries, net of cash received (22,878) 0
Net cash used in investing activities (27,113) (1,121)
Proceeds from borrowings 75,585 387
Debt issuance costs (10,016) (2,378)
Repayment of debt (5,821) (14,194)
Dividends paid   0
Increases (decreases) in cash related to intercompany advances and debt 0 0
Partial prepayment of put/call obligation 0 (14)
Issuance of common stock 0 2,830
Repurchases for tax withholdings on vesting of equity awards 0 (1,484)
Net cash provided by (used in) financing activities 59,748 (14,853)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,840 (3,580)
Net increase (decrease) in cash, cash equivalents and restricted cash (2,287) (63,673)
Cash, cash equivalents and restricted cash at beginning of period 178,055 380,223
Cash, cash equivalents and restricted cash at end of period 175,768 316,550
Eliminations    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities 0 0
Capital expenditures 0 0
Proceeds from asset dispositions 0 0
Cash transferred in sale of subsidiaries, net of cash received 0  
Net cash used in investing activities 0 0
Proceeds from borrowings 0 0
Debt issuance costs 0 0
Repayment of debt 0 0
Dividends paid   0
Increases (decreases) in cash related to intercompany advances and debt 0 0
Partial prepayment of put/call obligation   0
Issuance of common stock   0
Repurchases for tax withholdings on vesting of equity awards   0
Net cash provided by (used in) financing activities 0 0
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash at beginning of period 0 0
Cash, cash equivalents and restricted cash at end of period 0 0
Parent Company Only    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities (34,861) (32,865)
Capital expenditures (1,435) (654)
Proceeds from asset dispositions 0 0
Cash transferred in sale of subsidiaries, net of cash received 0  
Net cash used in investing activities (1,435) (654)
Proceeds from borrowings 37,500 0
Debt issuance costs (5,008) (421)
Repayment of debt 0 0
Dividends paid   162,941
Increases (decreases) in cash related to intercompany advances and debt (23,613) (162,519)
Partial prepayment of put/call obligation   (14)
Issuance of common stock   2,830
Repurchases for tax withholdings on vesting of equity awards   (1,484)
Net cash provided by (used in) financing activities 8,879 1,333
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash (27,417) (32,186)
Cash, cash equivalents and restricted cash at beginning of period 90,586 277,176
Cash, cash equivalents and restricted cash at end of period 63,169 244,990
Guarantor Subsidiaries    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities 10,847 11,992
Capital expenditures (2,538) (1,453)
Proceeds from asset dispositions 3,175 7,432
Cash transferred in sale of subsidiaries, net of cash received 0  
Net cash used in investing activities 637 5,979
Proceeds from borrowings 0 0
Debt issuance costs 0 (32)
Repayment of debt (1,701) (5,262)
Dividends paid   1,649
Increases (decreases) in cash related to intercompany advances and debt (9,534) (21,716)
Partial prepayment of put/call obligation   0
Issuance of common stock   0
Repurchases for tax withholdings on vesting of equity awards   0
Net cash provided by (used in) financing activities (11,235) (25,361)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 0
Net increase (decrease) in cash, cash equivalents and restricted cash 249 (7,390)
Cash, cash equivalents and restricted cash at beginning of period 3,205 8,904
Cash, cash equivalents and restricted cash at end of period 3,454 1,514
Non- Guarantor Subsidiaries    
Condensed Financial Statements, Captions [Line Items]    
Net cash used in operating activities (12,748) (23,246)
Capital expenditures (3,466) (6,788)
Proceeds from asset dispositions 29 342
Cash transferred in sale of subsidiaries, net of cash received (22,878)  
Net cash used in investing activities (26,315) (6,446)
Proceeds from borrowings 38,085 387
Debt issuance costs (5,008) (1,925)
Repayment of debt (4,120) (8,932)
Dividends paid   (164,590)
Increases (decreases) in cash related to intercompany advances and debt 33,147 184,235
Partial prepayment of put/call obligation   0
Issuance of common stock   0
Repurchases for tax withholdings on vesting of equity awards   0
Net cash provided by (used in) financing activities 62,104 9,175
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,840 (3,580)
Net increase (decrease) in cash, cash equivalents and restricted cash 24,881 (24,097)
Cash, cash equivalents and restricted cash at beginning of period 84,264 94,143
Cash, cash equivalents and restricted cash at end of period $ 109,145 $ 70,046